HLB Life Science CO.,LTD. Logo

HLB Life Science CO.,LTD.

Develops anti-cancer drugs and manufactures in vitro diagnostic medical devices.

067630 | KO

Overview

Corporate Details

ISIN(s):
KR7067630004
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄첨단산업1로 51-9 8층(영천동,엠타워지식산업센터), 화성시

Description

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-20 00:00
주식등의대량보유상황보고서(일반)
Korean 71.5 KB
2024-06-18 00:00
유상증자또는주식관련사채등의청약결과(자율공시)
Korean 10.1 KB
2024-06-17 00:00
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Korean 11.3 KB
2024-06-14 00:00
신주인수권행사가액의조정
Korean 12.7 KB
2024-06-12 00:00
유상증자최종발행가액확정
Korean 9.9 KB
2024-06-12 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 37.7 KB
2024-06-12 00:00
[발행조건확정]증권신고서(지분증권)
Korean 248.5 KB
2024-06-12 00:00
[기재정정]투자설명서
Korean 3.2 MB
2024-05-28 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.9 KB
2024-05-28 00:00
주식등의대량보유상황보고서(일반)
Korean 74.4 KB
2024-05-23 00:00
타인에대한담보제공결정
Korean 21.4 KB
2024-05-23 00:00
[기재정정]증권신고서(지분증권) (2024.06)
Korean 3.3 MB
2024-05-23 00:00
[기재정정]투자설명서
Korean 3.2 MB
2024-05-13 00:00
분기보고서 (2024.03)
Korean 1.9 MB
2024-05-13 00:00
[기재정정]증권신고서(지분증권) (2024.06)
Korean 3.8 MB

Automate Your Workflow. Get a real-time feed of all HLB Life Science CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Life Science CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Life Science CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.